Skip to main content
Clinical Trials/NCT02766738
NCT02766738
Completed
N/A

Improving Mobility in Residential Aged Care: Comparing the Benefits of Two Resistance Exercise Programs

Bond University1 site in 1 country84 target enrollmentMay 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Geriatric Disorder
Sponsor
Bond University
Enrollment
84
Locations
1
Primary Endpoint
Gait speed and spatio-temporal parameters (in a wider variety of walking tasks)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study aims to test which of three exercise programs, previously demonstrated valuable for residential aged care adults, has the greatest benefit for walking speed and the spatiotemporal parameters that define it. The programs to be included are:

  1. The GrACE program and
  2. The GrACE plus Gait specific training.

Detailed Description

This study will employ a non-randomised controlled design in which three different 24-week exercise programs and a non-exercising control group will be compared in the residential aged care (RAC) setting. The three programs are the GrACE and the GrACE plus a gait specific training program. Data Collection \~40 participants from two RAC facilities will be recruited into the study. This number of participants will provide 80% statistical power to identify moderate effect size between group differences on the primary outcome measures. The control group will be drawn from each of the RAC facility approached receiving exercise treatment. Participation will be informed by a discussion with the facilities Service Manager about the eligibility of participants and a medical history screen undertaken. All participants will provide informed written consent prior to participation. Participants in the exercise group will perform twice weekly training for 24 weeks. Data will be collected at 0 weeks, 12 weeks and 24 weeks in the control and exercise groups.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
January 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Sponsor
Bond University
Responsible Party
Principal Investigator
Principal Investigator

Samantha Fien

PhD Student

Bond University

Eligibility Criteria

Inclusion Criteria

  • aged over 65 years
  • residing in a RAC facility
  • able to walk with a walker and/or walking stick or can self-ambulate for the test (including those who have had knee and hip replacements)
  • can provide informed consent (Self- or by proxy).

Exclusion Criteria

  • end-stage terminal and/or life expectancy \<6-months (ethical reasons)
  • two person transfer or unable to self-ambulate (increased falls risk)
  • unable to communicate or follow instructions (personal needs beyond the scope of this project)
  • dangerous behaviours (endanger the client or research staff).

Outcomes

Primary Outcomes

Gait speed and spatio-temporal parameters (in a wider variety of walking tasks)

Time Frame: change from baseline to 24 weeks

Gait speed and spatio-temporal parameters will be recorded via the GaitMat II system (Manufacturer is EQInc; Model is GaitMat II), which required participants to walk across a level pressure mat system 3.66 m (11.91 ft.) long (McDonough et al. 2001). Participants completed the trials at their preferred (habitual) walking (gait) speed. All measures will be initiated from a standing start 2 m (6.56 ft.) from the GaitMat II platform as suggested by Kressig and Beauchet (Kressig \& Beauchet 2006) to reduce the effect that acceleration may have on gait speed. Three conditions will be measured which include normal walking, along with two dual tasks. These dual tasks include: (i) walking while carrying a glass of water in the participants preferred hand, (ii) walking while counting backwards from 30. Each of these gait conditions will be performed for three repetitions in a randomised block order (Taylor, 2012).

Secondary Outcomes

  • Sit to stand performance(change from baseline to 24 weeks)
  • handgrip strength(change from baseline to 24 weeks)
  • Body Composition(change from baseline to 24 weeks)
  • Quality of Life (EQ-5D-EL)(change from baseline to 24 weeks)
  • Sarcopenia status (SARC-F)(change from baseline to 24 weeks)

Study Sites (1)

Loading locations...

Similar Trials